GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrthoPediatrics Corp (NAS:KIDS) » Definitions » Debt-to-Revenue

OrthoPediatrics (OrthoPediatrics) Debt-to-Revenue : 0.07 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is OrthoPediatrics Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

OrthoPediatrics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.2 Mil. OrthoPediatrics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $9.9 Mil. OrthoPediatrics's annualized Revenue for the quarter that ended in Dec. 2023 was $150.5 Mil. OrthoPediatrics's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.07.


OrthoPediatrics Debt-to-Revenue Historical Data

The historical data trend for OrthoPediatrics's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrthoPediatrics Debt-to-Revenue Chart

OrthoPediatrics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.36 0.02 0.01 0.01 0.07

OrthoPediatrics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.07

Competitive Comparison of OrthoPediatrics's Debt-to-Revenue

For the Medical Devices subindustry, OrthoPediatrics's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrthoPediatrics's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OrthoPediatrics's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where OrthoPediatrics's Debt-to-Revenue falls into.



OrthoPediatrics Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

OrthoPediatrics's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.152 + 9.908) / 148.732
=0.07

OrthoPediatrics's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.152 + 9.908) / 150.452
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.


OrthoPediatrics Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of OrthoPediatrics's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


OrthoPediatrics (OrthoPediatrics) Business Description

Traded in Other Exchanges
Address
2850 Frontier Drive, Warsaw, IN, USA, 46582
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
Executives
Terry D Schlotterback director 2850 FRONTIER DRIVE, WARSAW IN 46582
Fred Hite director, officer: Chief Financial Officer ORTHOPEDIATRICS, 2850 FRONTIER DR., WARSAW IN 46582
Dyer George Sinclair Mitchell director 55 ORCHARD ST., CAMBRIDGE MA 02140
Gregory A Odle officer: Executive Vice President 2850 FRONTIER DRIVE, WARSAW IN 46582
Joseph W Hauser officer: Sr VP & GM Trauma & Deformity 6428 RIDGELINE DR, HUDSON OH 44236
Jimmy Duane Mcdonald director 28662 N. 71ST STREET, SCOTTSDALE AZ 85226
David R Pelizzon director, 10 percent owner 2850 FRONTIER DR, WARSAW IN 46582
Squadron Capital Holdings Llc 10 percent owner 18 HARTFORD AVENUE, PO BOX 223, GRANBY CT 06053
Squadron Capital Llc 10 percent owner 2850 FRONTIER DR., WARSAW IN 46582
Harold Ruf director 2850 FRONTIER DR, WARSAW IN 46582
Jennifer N. Pritzker 10 percent owner C/O SQUADRON CAPITAL LLC, 104 S. MICHIGAN AVENUE, SUITE 500, CHICAGO IL 60603
Infante (reynolds) Marie C director 2850 FRONTIER DR, WARSAW IN 46582
Stephen F Burns director 2850 FRONTIER DRIVE, WARSAW IN 46582
Berry Bernie B Iii director 2850 FRONTIER DRIVE, WARSAW IN 46582
Mark C Throdahl director, officer: President and CEO ORTHOPEDIATRICS, 2850 FRONTER DR., WARSAW IN 46582